Sign up for e-mail alerts
|
Login
|
About PlusNews
|
Français
PlusNews
Global HIV/AIDS news and analysis
Advanced Search
GLOBAL
AFRICA
East Africa
Kenya
Sudan
Tanzania
Uganda
Great Lakes
Burundi
Central African Republic
Congo
DRC
Rwanda
Horn of Africa
Djibouti
Eritrea
Ethiopia
Somalia
Southern Africa
Angola
Botswana
Comoros
Lesotho
Madagascar
Malawi
Mauritius
Mozambique
Namibia
Seychelles
South Africa
Swaziland
Zambia
Zimbabwe
West Africa
Benin
Burkina Faso
Cameroon
Cape Verde
Chad
Cote d'Ivoire
Gabon
Gambia
Ghana
Equatorial Guinea
Guinea
Guinea-Bissau
Liberia
Mali
Mauritania
Niger
Nigeria
Sao Tome and Principe
Senegal
Sierra Leone
Togo
Western Sahara
ASIA
Afghanistan
Cambodia
Indonesia
Kyrgyzstan
Myanmar
Nepal
Pakistan
Papua New Guinea
Philippines
Sri Lanka
Thailand
Uzbekistan
MIDDLE EAST
Egypt
Iraq
Jordan
Lebanon
OPT
Yemen
AMERICAS
Haiti
30 July 2012
Home
Global Issues
In-Depth
Blog
Events
IRIN
Film
Weekly Reports
Countries
Afghanistan
Angola
Bangladesh
Benin
Botswana
Burkina Faso
Burundi
Cambodia
Cameroon
Cape Verde
Central African Republic (CAR)
Chad
Comoros
Republic of Congo
Cote d'lvoire
Djibouti
Democratic Republic of Congo (DRC)
Egypt
Equatorial Guinea
Eritrea
Ethiopia
Gabon
Gambia
Ghana
Guinea
Guinea-Bissau
Haiti
Indonesia
Iran
Iraq
Jordan
Kenya
Kyrgyzstan
Laos
Lebanon
Lesotho
Liberia
Madagascar
Malawi
Mali
Mauritania
Mauritius
Mozambique
Myanmar
Namibia
Nepal
Niger
Nigeria
occ. Palestinian terr.
Pakistan
Papua New Guinea
Philippines
Rwanda
Sao Tome and Principe
Senegal
Seychelles
Sierra Leone
Somalia
South Africa
Sri Lanka
Sudan
Swaziland
Syria
Tajikistan
Tanzania
Thailand
Timor-Leste
Togo
Turkmenistan
Uganda
Uzbekistan
Western Sahara
Yemen
Zambia
Zimbabwe
Themes
Aid Policy
Arts/Culture
Care/Treatment
Children
Conflict
Early Warning
Economy
Education
Environment
Food Security
Gender Issues
Governance
Health & Nutrition
HIV/AIDS
Media
Migration
Prevention
PWAs/ASOs
Stigma/Human Rights/Law
Urban Risk
Youth
Most read
In-depth: TB - the year that was
GLOBAL: Straight Talk with Eric Goosby, head of PEPFAR
Photo: PEPFAR
Ambassador Eric Goosby, United States Global AIDS Coordinator
VIENNA, 26 July 2010 (PlusNews) - The US president's Emergency Plan for AIDS Relief (PEPFAR) has committed about US$32 billion to the global fight against HIV since its launch in 2003, making it the largest donor for HIV/AIDS globally. Following annual increases in contributions, however, PEPFAR has effectively flat-lined funding from 2009.
IRIN/PlusNews spoke to Ambassador Eric Goosby, head of PEPFAR since June 2009, about how lower funding levels are likely to impact HIV programmes:
QUESTION:
Why has President Barack Obama retreated on his campaign promise to provide at least $50 billion by 2013 for the global fight against AIDS?
ANSWER:
President Obama has taken the number of people that PEPFAR pays for from 1.6 million to 2.5 million and has pledged through 2013 to cover over four million people on ARVs [antiretroviral treatment]. That's not a backing away.
The backing away is a perception because of the drop in the funding trajectory compared to other years. The reason for that is really the economic decline. The US has been heavily hit and as a result the president has flat-funded or decreased funding in every programme in the US government, except the military and development. We come under development and that’s why we have our increase which was small, just 3 percent.
Q:
With flat-funding in many programmes, how does PEPFAR hope to achieve increased numbers on treatment?
A:
The efficiencies are big; we do not expect any major drop in accrual of patients on treatment over the next couple of years because we have enough fat in the system to redirect resources and get smarter at delivering services. After seven years of doing this, we are better at it. When we started PEPFAR, it cost over $1,000 per patient [on treatment] per year; that figure is now in the low four hundreds.
As a result of the availability of cotrimoxazole [an antibiotic used to prevent HIV-related infections], earlier initiation of treatment and availability of diagnosis and treatment of tuberculosis, we are not treating opportunistic infections at anywhere near the rate we used to. The in-patient need has dropped off; we have moved this thing almost to an out-patient disease in many countries.
All of these are huge cost-savings - with the same PEPFAR amount, we are able to redirect those resources towards treatment expansion.
We are [also] making administrative changes, in procurement-distribution - for example, where we have one administrator for 20 clinics rather than 20 separate administrators for each clinic.
We have pretty much exhausted the move from brand [-name ARVs] to generics. We are more than 90 percent generic in PEPFAR-funded programmes. We need to get generics in second-line and we are a strong motor behind getting that straight.
Q:
Why has PEPFAR maintained the so-called "anti-prostitution pledge" that effectively leaves sex workers - a high risk group for HIV - out of PEPFAR’s programmes?
A:
What the clause really was focused on was to ensure that PEPFAR did not fund organizations involved in trying to legalize prostitution and traffic women into prostitution. We have changed it so an organization doesn’t have to sign [a separate document pledging to oppose sex work and sex-trafficking]; we have folded in an agreement that the [beneficiary] organization will not traffic women into prostitution - there is no separate document.
If someone feels they were excluded or dropped put of care for [being a sex worker], we would get on that like a laser
PEPFAR has not de-funded any programme on the planet for these reasons. We want to care for every sex worker out there. If a sex worker comes into any of our facilities, that person will be embraced and followed for the duration of their life on antiretrovirals.
If there are examples of anybody being turned away [for being a sex worker], if someone feels that they were excluded from or dropped out of care for those reasons, we would get on that like a laser.
Q:
Why is there so little pressure from donors on African governments to take responsibility for funding their own HIV/AIDS programmes?
A:
Our partner governments don’t feel the need to increase or maintain funding as PEPFAR or Global Fund [to Fight AIDS, Tuberculosis and Malaria] resources come into their countries. We need to hold our partner countries responsible for their populations and they need to maintain and increase funding lines.
Since I’ve been in office, every country I visit, I meet the president and minister of health and often the finance minster and have this discussion. Our partnership framework mechanism - a new process to engage in a different dialogue with countries around country ownership - brings that up as a centre-plate expectation. We are telling our partners: “Here’s how much we’re putting in for the following functions, how much are you putting in?”
We’re translating the human resources, the bricks and mortar, electricity or operational costs of a plant, into their costs as well as whatever resources they put into labs and drugs and procurement - countries do much of that. Once that baseline is established, we will hold an expectation that they maintain it and when they can, increase it, with specific percentages talked about.
The flip side to this is that the US government will not [use] a population that we are currently caring for with drug support or care support or in our prevention activities as a leverage point to force a government into putting more money toward this effort by abandoning or diminishing our contribution.
kr/ks/cb
TB - the year that was
March 2011
Film
Neglected Diseases - Drug Resistant TB
IRIN's TB reports
MYANMAR: Funding, access challenges to TB treatment
PAPUA NEW GUINEA: MDR-TB an emerging “health emergency”
In Brief: TB, HIV warning for Cambodia's prisons
SOMALIA: Khat-chewing "contributes to rise in Burao TB patients"
BANGLADESH: TB rates plummet, but still high among poor and uneducated
In-Depth Feedback
PlusNews welcomes feedback. Send your messages to feedback.
Other OCHA Sites
Donors